In contrast, the experts noted that several recent FDA approvals introduced first-in-class therapies to the oncology landscape. 1 Among these are menin inhibitors, which block the interaction between ...

Oct 24 (Reuters) - A newer class of cancer drugs can delay disease progression or extend survival for breast cancer patients, multiple teams of researchers reported at a major European oncology ...

Shortages to backbone chemotherapy drugs are negatively affecting patient care, and more shortages are likely without policy solutions, experts say.

We were the first in Europe to develop chemotherapeutic agents. We discovered, and with The Royal Marsden developed, the chemotherapy drugs busulfan, chlorambucil, melphalan and carboplatin, which are ...

Findings reveal the likely reason why certain chemotherapies are effective for many patients. Importantly, they also help explain why attempts to find new chemo drugs based solely on stopping cellular ...

Cancer cells rapidly adapt to treatments, developing resistance that makes chemotherapy less effective. Researchers used an existing anti-inflammatory drug to disrupt cancer cells’ ability to adapt by ...

A naturally-occurring protein that tends to be expressed at higher levels in breast cancer cells boosts the effectiveness of ...

Drug shortages have reached an all-time high in the United States. During the first three months of 2024, there were 323 drugs in active shortage, according to data from the American Society of Health ...

A new study from the University of Wisconsin–Madison suggests that chemotherapy may not be reaching its full potential, in part because researchers and doctors have long misunderstood how some of the ...

Better care for cancer patients may be on the horizon. A new prescription medicine for treating cervical cancer has been showing positive results in clinical trials. In phase 3 global trials, TIVDAK ...

Drug shortages have reached a record high in the first three months of 2024. In the first quarter of the year, 323 drugs were running low, surpassing the 2014 high of 320, according to data provided ...

A new wave of cancer treatments is looking promising for the future of oncologic care. The ovarian cancer drug RC88, which is made by the Chinese biopharmaceutical company RemeGen, received FDA ...